Comera Life Sciences Holdings Inc
OTC:CMRA
Cash Flow Statement
Cash Flow Statement
Comera Life Sciences Holdings Inc
| Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(5)
|
(8)
|
(15)
|
(25)
|
(18)
|
(18)
|
(10)
|
(9)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
1
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Other Non-Cash Items |
1
|
1
|
5
|
12
|
6
|
6
|
1
|
1
|
|
| Change in Working Capital |
1
|
0
|
1
|
2
|
3
|
3
|
2
|
1
|
|
| Cash from Operating Activities |
(4)
N/A
|
(6)
-63%
|
(8)
-32%
|
(11)
-37%
|
(10)
+12%
|
(9)
+10%
|
(7)
+19%
|
(7)
+7%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cash from Investing Activities |
(0)
N/A
|
0
N/A
|
(0)
N/A
|
(0)
-47%
|
(0)
+87%
|
(0)
-309%
|
(0)
-2%
|
(0)
+21%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
10
|
17
|
13
|
14
|
5
|
4
|
1
|
0
|
|
| Net Issuance of Debt |
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
(0)
|
0
|
(1)
|
0
|
2
|
2
|
6
|
|
| Cash from Financing Activities |
10
N/A
|
18
+73%
|
14
-20%
|
14
+1%
|
5
-64%
|
7
+26%
|
3
-58%
|
6
+110%
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
6
N/A
|
3
-46%
|
6
+74%
|
3
-49%
|
(5)
N/A
|
(2)
+49%
|
(4)
-92%
|
(1)
+80%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(4)
N/A
|
(6)
-57%
|
(8)
-34%
|
(11)
-37%
|
(10)
+13%
|
(9)
+9%
|
(7)
+19%
|
(7)
+7%
|
|